It has been proven that autophagy in human prostate cancer cells is induced by PKM2 knockdown via the Akt/mTOR pathway [17], and a specific PKM2 inhibitor, compound 3K, also promoted the cell death of SK-OV-3 via restraining the Akt/mTOR pathway [18]. Here, AKT1 is linked to prostate carcinoma.